RxDoctor Payments Data

Ailisa Smith, MD

Family Medicine · Hickory, NCNPI 1356479828

Payments from drug & device makers

$6,002in general payments, 2019–2025

Across 374 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$503
  • Novo Nordisk$495
  • Pfizer$377
  • AstraZeneca$376
  • Amgen$369
  • plus $3K from 43 others

What the payments were for

  • Food & beverage$5,988100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,002 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$197,498
Medicare patients
421
Services billed
2,853

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide231$251,976
EliquisApixaban259$234,501
MounjaroTirzepatide153$178,767
RybelsusSemaglutide111$144,261
JardianceEmpagliflozin81$57,720
Tresiba Flextouch U-200Insulin Degludec40$57,052
FarxigaDapagliflozin Propanediol58$54,968
TrulicityDulaglutide52$49,868
Tresiba Flextouch U-100Insulin Degludec66$36,446
LinzessLinaclotide34$35,736
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$33,717
MyrbetriqMirabegron43$30,024
ProliaDenosumab16$27,995
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog30$26,397
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog44$25,546

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$495$396,237342 claims
PfizerEliquis$377$234,501259 claims
Lilly USA, LLCMounjaro, Trulicity$246$228,634205 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$376$79,548101 claims
Boehringer IngelheimJardiance, Stiolto Respimat$44$73,046105 claims
AbbVieLinzess, Synthroid$1,007$45,822136 claims
GSKTrelegy Ellipta, Breo Ellipta$503$38,30955 claims
MerckBelsomra, Januvia$52$31,86755 claims
Astellas Pharma US IncMyrbetriq$86$30,02443 claims
AmgenProlia$369$27,99516 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$326$11,66114 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$71$7,993929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →